Abe M - Search Results

1

Unusual Manifestation of Graves' Disease: Ventricular Fibrillation.

Kobayashi H, Haketa A, Abe M, Tahira K, Hatanaka Y, Tanaka S, Ueno T, Soma M. Kobayashi H, et al. Among authors: abe m. Eur Thyroid J. 2015 Sep;4(3):207-12. doi: 10.1159/000437225. Epub 2015 Aug 26. Eur Thyroid J. 2015. PMID: 26558239 Free PMC article.

2

Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis.

Abe M, Okada K, Maruyama T, Maruyama N, Soma M, Matsumoto K. Abe M, et al. Expert Opin Pharmacother. 2010 Jul;11(10):1611-20. doi: 10.1517/14656566.2010.495119. Expert Opin Pharmacother. 2010. PMID: 20540652 Clinical Trial.

3

Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.

Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, Matsumoto K, Soma M. Abe M, et al. Expert Opin Investig Drugs. 2010 Sep;19(9):1027-37. doi: 10.1517/13543784.2010.505918. Expert Opin Investig Drugs. 2010. PMID: 20649501 Clinical Trial.

4

Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.

Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, Matsumoto K, Soma M. Abe M, et al. Hypertens Res. 2011 Feb;34(2):268-73. doi: 10.1038/hr.2010.221. Epub 2010 Dec 2. Hypertens Res. 2011. PMID: 21124330 Clinical Trial.

5

Relationship between erythropoietin responsiveness, insulin resistance, and malnutrition-inflammation-atherosclerosis (MIA) syndrome in hemodialysis patients with diabetes.

Abe M, Okada K, Maruyama T, Maruyama N, Matsumoto K, Soma M. Abe M, et al. Int J Artif Organs. 2011 Jan;34(1):16-25. doi: 10.5301/ijao.2011.6314. Int J Artif Organs. 2011. PMID: 21298620

6

Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice.

Abe M, Okada K, Soma M. Abe M, et al. Curr Drug Metab. 2011 Jan;12(1):57-69. doi: 10.2174/138920011794520053. Curr Drug Metab. 2011. PMID: 21303332 Review.

7

Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis.

Abe M, Okada K, Ikeda K, Matsumoto S, Soma M, Matsumoto K. Abe M, et al. Artif Organs. 2011 Apr;35(4):398-403. doi: 10.1111/j.1525-1594.2010.01112.x. Epub 2011 Feb 14. Artif Organs. 2011. PMID: 21314833

8

A case of femoral hemorrhage in a patient with microscopic polyangiitis with low levels of myeloperoxidase-antineutrophil cytoplasmic autoantibody.

Abe M, Okada K, Maruyama N, Matsumoto S, Fuke Y, Fujita T, Soma M, Matsumoto K. Abe M, et al. Clin Exp Nephrol. 2011 Jun;15(3):414-418. doi: 10.1007/s10157-011-0406-4. Epub 2011 Feb 12. Clin Exp Nephrol. 2011. PMID: 21318302

9

Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy.

Fujita T, Shimizu C, Fuke Y, Satomura A, Abe M, Kaizu K, Matsumoto K, Soma M. Fujita T, et al. Among authors: abe m. Diabetes Res Clin Pract. 2011 Jun;92(3):e66-9. doi: 10.1016/j.diabres.2011.02.028. Epub 2011 Mar 26. Diabetes Res Clin Pract. 2011. PMID: 21440322

10

Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.

Abe M, Maruyama N, Okada K, Matsumoto S, Matsumoto K, Soma M. Abe M, et al. Hypertens Res. 2011 Aug;34(8):935-41. doi: 10.1038/hr.2011.67. Epub 2011 Jun 9. Hypertens Res. 2011. PMID: 21654755 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,066 results

Search Page